Requires NJT to establish pilot program to supply certain light rail train sets with opioid antidotes; makes appropriation of $100,000.

This bill requires New Jersey Transit (NJT) to create a two-year pilot program on light rail trains operating in southern New Jersey, supplying each train set with opioid antidotes (like naloxone) and establishing secure storage with silent alerts to train operators when accessed. NJT must stock at least two doses per train, maintain bilingual signage and informational cards for passengers, and track antidote usage without requiring staff to administer the antidote or undergo specialized training. The program is funded by a $100,000 appropriation from the General Fund, and NJT must submit a report on its effectiveness to the Governor and Legislature within six months of the pilot's conclusion. The bill directly affects NJT operations, light rail staff, and passengers who may experience or witness opioid overdoses on southern NJ light rail services.